Leicester researchers review next generation of obesity treatments
A team of Leicester researchers have published a review exploring a new generation of medicines that could transform treatment for obesity and type 2 diabetes.
Significant Effects of Weight Loss Medicine Study Presented at US Conference
The findings of a study looking at the effects of weight loss medicine, CagriSema, have showed it resulted in an average weight reduction in the highest range of any existing …
UK study in over 80,000 adults finds smokers tend to eat less and have a less healthy diet than non-smokers
New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May 2024), suggests that smokers tend to eat less and have less healthy eating …
International studies confirm positive effects of weight loss medicine for people with obesity-related heart failure
Two new studies have confirmed the benefits of weight loss medication, semaglutide, for patients living with obesity-related heart failure.
Leicester study seeks to understand ongoing impacts of exercise after weight loss surgery
“I hope what they learn in this study will benefit people like me, who are committed to managing their weight after baratric surgery.”
Weight re-gained after weight loss results in less muscle, more fat, study finds
A Leicester study that measured the fat mass and fat-free (muscle) mass of dieters suggests that weight loss followed by weight regain has a negative impact on muscle mass.
Findings of international study could prove to be huge step forward in the treatment of heart failure
Professor Melanie Davies, Director of the National Institute for Health and Care Research Leicester Biomedical Research Centre (BRC), played a central role in new study which has shown that the …
Significant weight loss and blood sugar control seen in patients with type 2 diabetes following new medication combination
An international team, including the Director of the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC), that studied the combined effects of semaglutide with cagrilintide …